Mizuho Securities

Plus Power engages in the development, ownership, and operation of independent battery energy storage systems, delivering capacity, energy, and ancillary services. This facilitates the swift integration of renewable generation resources.

Suono Bio is a biotechnology company enabling ultra-rapid delivery of novel therapeutics to the gastrointestinal tract. The company's mission is to harness its proprietary therapeutic platform to transform the treatment of difficult-to-treat diseases by enabling localized delivery of small molecules, biologics, nucleic acids, and gene therapies without the need for encapsulation.

One Tap BUY provides my banker, the financial smartphone application. The application allows its users to select the stocks they want to buy and sell, helps them to decide amounts, and buy stocks by spending a lesser amount of money. Stocks can be traded throughout the day and it also allows its users to buy and sell only profits and keep the stocks with them.

PayPay is an online payment application. This benefit is not applicable when paying with PayPay online payment service. For PayPay, per person, the granting limit for one payment is equivalent to 15,000 yen, and the total granting limit for one month is equivalent to 30,000 yen.

HiJoJo Partners sells "funds incorporating high-quality middle and late-stage private companies in Japan and overseas, including unicorn companies," to domestic investors.

One Tap BUY provides my banker, the financial smartphone application. The application allows its users to select the stocks they want to buy and sell, helps them to decide amounts, and buy stocks by spending a lesser amount of money. Stocks can be traded throughout the day and it also allows its users to buy and sell only profits and keep the stocks with them.

Visco Technologies is a manufacturing company that develops, manufactures, sells, and maintains machine vision and image processing systems.

PayPay is an online payment application. This benefit is not applicable when paying with PayPay online payment service. For PayPay, per person, the granting limit for one payment is equivalent to 15,000 yen, and the total granting limit for one month is equivalent to 30,000 yen.

One Tap BUY provides my banker, the financial smartphone application. The application allows its users to select the stocks they want to buy and sell, helps them to decide amounts, and buy stocks by spending a lesser amount of money. Stocks can be traded throughout the day and it also allows its users to buy and sell only profits and keep the stocks with them.

One Tap BUY provides my banker, the financial smartphone application. The application allows its users to select the stocks they want to buy and sell, helps them to decide amounts, and buy stocks by spending a lesser amount of money. Stocks can be traded throughout the day and it also allows its users to buy and sell only profits and keep the stocks with them.

PayPay is an online payment application. This benefit is not applicable when paying with PayPay online payment service. For PayPay, per person, the granting limit for one payment is equivalent to 15,000 yen, and the total granting limit for one month is equivalent to 30,000 yen.

SE Holdings and Incubations Co., Ltd. is a Japan-based holding company that operates in six business segments. The Publishing segment is engaged in the publication and sale of general books, translation version books and computer-related books and magazines, the computer-related conference and education, the provision of computer-related technical information on Websites and the sale of software and hardware online. The Corporate Services segment provides product marketing and sales promotion, user support and public relations (PR) and investor relations (IR) support services. The Software Network segment is engaged in the development and sale of entertainment software, the provision of Internet technologies and maintenance services for cellular phones and the operation of amusement facilities. The Internet Cafe segment operates Internet cafes. The Education and Personnel segment is engaged in the manpower dispatching business. The Others segment manages real estate properties.

Perlegen Sciences engages in the discovery and commercialization of genetic variations that provide physicians with information to improve the clinical decision-making process and patient treatment outcomes. Its products include MammaPLUS, a breast cancer risk stratifier and a panel of common genetic variants that stratifies individual genetic and background/clinical risk for those at moderately elevated risk for non-familial breast cancer, as well as impacts the risk for developing invasive breast cancer; and Genotype Browser Website that provides a way to access and view the results of a study of genetic variation in various diverse human populations. Perlegen Sciences, Inc. was founded in 2000 and is based in Mountain View, California.

SMS is mainly engaged in the information operation businesses in nursing care, healthcare, career, senior life and overseas fields to business operators and end user, among others.

Perlegen Sciences engages in the discovery and commercialization of genetic variations that provide physicians with information to improve the clinical decision-making process and patient treatment outcomes. Its products include MammaPLUS, a breast cancer risk stratifier and a panel of common genetic variants that stratifies individual genetic and background/clinical risk for those at moderately elevated risk for non-familial breast cancer, as well as impacts the risk for developing invasive breast cancer; and Genotype Browser Website that provides a way to access and view the results of a study of genetic variation in various diverse human populations. Perlegen Sciences, Inc. was founded in 2000 and is based in Mountain View, California.

SOURCENEXT provides utility software and software products for training purposes. They sell through mobile phone operators, directly through their own online stores, and wholesale to home appliance discount stores and other electronic commerce websites.

MediciNova is a biopharmaceutical company focused on acquiring and developing novel, small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Through strategic alliances primarily with Japanese pharmaceutical companies, MediciNova holds rights to a diversified portfolio of clinical and preclinical product candidates, each of which MediciNova believes has a well-characterized and differentiated therapeutic profile, attractive commercial potential and patent assets having claims of commercially adequate scope. MediciNova’s pipeline includes clinical-stage compounds for the treatment of acute exacerbations of asthma and COPD, progressive multiple sclerosis, methamphetamine addiction, neuropathic pain, asthma, interstitial cystitis, and solid tumor cancers